Texas HIV Medication Program
Apply | Questions? | Contact Us
The Texas HIV Medication Program (THMP) provides medications for the treatment of HIV and its related complications for low-income Texans. To qualify for medications, potential clients who meet eligibility criteria complete an application for assistance. Once approved, a client receives medications at an assigned pharmacy in their community.
To learn more about the THMP and find out if you are eligible, see the Frequently Asked Questions. You can apply for the program by visiting TakeChargeTexas (TCT) or downloading and completing the client application. Be sure and review the specific “application instructions” when completing the application. The application and its instructions are located on the THMP document page. If you have more questions or need assistance completing your application, call the THMP toll-free at 800-255-1090.
The THMP is the official AIDS Drug Assistance Program (ADAP) for the State of Texas. The THMP started in 1987 and provides medications approved by the Food and Drug Administration (FDA) for the treatment of illnesses caused by HIV and other opportunistic infections in people living with HIV as prescribed by their doctor. THMP also operates the Texas HIV State Pharmaceutical Assistance Program (SPAP), which helps people living with HIV who do not qualify for the full Low-Income Subsidy (extra help) with their out-of-pocket costs associated with Medicare Part D prescription drug plans, including co-payments, deductibles, coinsurance, and during the coverage gap (the "donut hole").
THMP Email List
Sign up to one or more email lists below today to receive timely and relevant news from THMP:
Subscribe to THMP News – News about significant events for the THMP program.
Subscribe to THMP Participating Pharmacies – Updates of interest to THMP participating pharmacies.
Subscribe to THMP Eligibility – Information for ADAP Enrollment Workers (AEW) and others who assist clients in THMP application submission and their supervisors.
THMP to Offer Insurance Assistance Services Starting in January 2025
The Texas HIV Medication Program (THMP) will begin providing insurance assistance services for people living with HIV who are eligible for the AIDS Drug Assistance Program (ADAP). For more information, please visit the THMP ADAP eligibility requirements page.
ADAP will pay for premiums and prescription drug copayments for eligible health insurance plans starting in January 2025. THMP will enroll clients in insurance plans, including plans on the federal Health Insurance Marketplace (Affordable Care Act plans), during the upcoming open enrollment period from November 1, 2024, through January 15, 2025. More information is coming soon on how clients can enroll. THMP encourages you to subscribe to the THMP News to stay updated.
THMP looks forward to working with stakeholders and clients on this important new service.
Register for the TakeChargeTexas (TCT) Pharmacy Portal
The TakeChargeTexas (TCT) Pharmacy Portal rollout is now available.
Participating pharmacies must complete the Data Security and Confidentiality course as detailed in the Security and Confidentiality Training, Security and Confidentiality Course Instructions before registering for TCT access in the Enterprise Portal. Once completed, pharmacies email a copy of the certificate to TBHIVSTD.AccountRequests@dshs.texas.gov.
Training is available on the TCT website.
Pharmacies can request TCT access at iamonline.hhs.state.tx.us. The IAMOnline Transition Guide contains instructions to register as a pharmacy.
Please email medication@dshs.texas.gov if you have any questions about this notification, or email the TCT Help Desk at TCTHelpDesk@dshs.texas.gov for assistance with technical issues.
Attention TCT Users: IAMOnline Replaced the Enterprise Portal
What is IAMOnline?
IAMOnline is the new HHS Identity Management Solution, replacing the HHS Enterprise Portal. It includes a simplified log-in experience with single sign-on (SSO) and streamlined access management processes.
Why do you need to know?
HHS discontinued the HHS Enterprise Portal. TCT transitioned to a new portal, IAMOnline, for access management. All TCT users, including third-party vendors, partners, providers, and non-HHS staff, must have an IAMOnline account to access TCT.
The way you log into TCT did not change. The only thing that did change is that the system directs you to IAMOnline when changing your password.
Existing external client portal users:
- Login through the Client Portal Public Website.
- Log into the TCT client portal website using your existing TCT username and password.
- If you forgot your password, click the Forgot Password link to go to the IAMOnline website to change your password.
- New client users will click Register and Apply on the Citizen User Portal to create a new account.
If you need further assistance, please email tcthelpdesk@dshs.texas.gov.
THMP Notification Regarding Standard Deduction
The Texas Department of State Health Services (DSHS) has an important notification for participants of the Texas HIV Medication Program (THMP). Please review the information provided and contact us at 1-800-255-1090 or hivstd@dshs.texas.gov if you have any questions. Please do not include personal identifying information about a THMP applicant or participant via email.
THMP uses a standard deduction to adjust the household income for applicants, new applicants and recertifications, for eligibility purposes. THMP recalculates the standard deduction amount each year. The annual standard deduction amount for April 16, 2024, to March 31, 2025 is $11,177, which is a decrease from the previous year's amount of $12,240.
To calculate the annualized average per-client expenditure, THMP uses the previous state fiscal year's expended amount to determine the average amount spent on each client, which is then annualized on a per-client basis to determine the standard deduction.
Existing program participants will have their income eligibility reviewed at the next scheduled program recertification. Participants are required to submit recertification applications by the last day of their birth month, and their eligibility will be based on their income at the time of recertification.
Case managers should update impacted clients.
Formulary Addition
A medication has been added to the THMP Formulary as a 90-day option:
- Delstrigo-90 Day (doravirine/lamivudine/tenofovir), 100/300/300 mg tablets, #30 per bottle (to be ordered for 3 bottles)
The Medical Certification Form and THMP Formulary have been updated. Both can be found on the THMP documents page.
Texas HIV Medication Program Notifications
DSHS has three important notifications for clients participating in THMP. Please review the information provided and contact us at 1-800-255-1090 or hivstd@dshs.texas.gov if you have any questions.
THMP began using a new method to determine eligibility for the program in 2023. The new method created a more equitable and transparent eligibility process.
Previously, THMP determined financial eligibility by subtracting personal HIV drug costs from a person’s income. Beginning in 2023, THMP determined financial eligibility by subtracting $12,240 from a person’s income. This standard deduction is the average drug cost per THMP client. Each year, THMP will adopt a new standard deduction amount of the average client drug cost.
THMP uses the standard deduction to determine your eligibility during your annual recertification period. If your recertification period was after April 1, 2023, your eligibility remained the same until your next annual recertification. At that time, THMP used the new method to determine your eligibility.
You should contact your case worker to understand how this change will affect you.
Second, THMP reinstated the ten medications below, effective April 1, 2023.
These medications are available to new and existing enrollees. Existing participants received a letter by March 1, 2023, informing them that these medications were available.
Name Brand (Generic) | Indications |
---|---|
Amlodipine | Hypertension |
Atorvastatin | Statin |
Hydrochlorothiazide (HCTZ) | Hypertension |
Lisinopril | Hypertension |
Metformin HCL | Diabetes |
Metoprolol Tartrate | Hypertension |
Trazadone | Psychiatric |
Duloxetine | Psychiatric |
Gabapentin | Psychiatric |
Sertraline | Psychiatric |
Please share this information with those you know this change may impact.
Third, if you are a current Take Charge Texas (TCT) user and would like to provide feedback on future enhancements, contact THMP at hivstd@dshs.texas.gov and include “TCT Feedback” in the subject line.
THMP will invite those who email to see demonstrations of future system enhancements and give you the opportunity to provide feedback upon viewing the demonstration.
New Dosages of Three Medications Used To Treat HIV in Infants and Children Have Been Approved for Addition to the THMP Formulary
New dosages of three medications used to treat HIV in infants and children have been approved by the Department of State Health Services (DSHS) Commissioner of Health in addition to the Texas HIV Medication Program (THMP) AIDS Drug Assistance Program (ADAP) Formulary:
- Tivicay PD (dolutegravir) 25 mg
- Isentress (raltegravir) 25 mg
- low-dose Biktarvy (bictegravir 30 mg/emtricitabine 120 mg/tenofovir alafenamide 15 mg)
DSHS was able to estimate the fiscal impact of this change with reasonable certainty based on current data related to pediatric client loads and medication usage. The estimated fiscal impact of this change is minimal, with the possibility of a resulting positive fiscal impact when compared with maintaining only the current pediatric options. Consequently, DSHS is able to support these additions within existing monies and has approved adding these pediatric medications to the formulary.
THMP updated its formulary.
Please submit a new THMP Medical Certification Form (MCF) for any infants and children in need of these new medication doses.
Thanks to the Medication Advisory Committee for recommending these changes.
Book traversal links for Texas HIV Medication Program
- About the DSHS HIV/STD Program
- Contact Us
-
-
- HIV Administrative Agencies
- HIV/STD Service Providers – Abilene – Amarillo – Arlington – Austin
- HIV/STD Service Providers – Beaumont – Belton – Bryan
- HIV/STD Service Providers – Cameron – Cleveland – Corpus Christi – Cotulla
- HIV/STD Service Providers – Dallas – Denton
- HIV/STD Service Providers – Eagle Pass – El Paso
- HIV/STD Service Providers – Farmers Branch – Fort Worth
- HIV/STD Service Providers – Galveston
- HIV/STD Service Providers – Hallettsville – Harlingen – Hillsboro – Houston
- HIV/STD Service Providers – Killeen – Kingsville
- HIV/STD Service Providers – Laredo – Longview – Lubbock – Lufkin
- HIV/STD Service Providers – McAllen – McKinney – Midland
- HIV/STD Service Providers – Nacogdoches – Odessa
- HIV/STD Service Providers – Palestine – Plano – Richmond – Robstown
- HIV/STD Service Providers – San Angelo – San Antonio – San Marcos – Sherman
- HIV/STD Service Providers – Temple – Texarkana – Texas City – Tyler
- HIV/STD Service Providers – Uvalde – Victoria – Waco – Wichita Falls
- HIV and STD Testing in Texas
-
-
- Epi Profile – Data Sources and Notes
- Epi Profile Section 1 – Executive Summary
- Epi Profile Section 2 – Texans Living with HIV in 2018
- Epi Profile Section 3 – Texans with New HIV Diagnoses
- Epi Profile Section 4 – New Diagnoses in MSM
- Epi Profile Section 5 – Texans with Newly Acquired HIV
- Epi Profile Section 6 – Deaths in Texans Living with HIV
- Epi Profile Section 7 – Comorbidities in Texans Living with HIV
- Epi Profile Section 8 – HIV Testing in Programs Funded by the Department of State Health Services
- Epi Profile Section 9 – Sex and Substance Use in PLWH
- Epi Profile Section 10 – Sex and Substance Use in People at Increased Risk for HIV in Dallas, Texas
- Epi Profile Section 11 – HIV Treatment Cascade
- Epi Profile - Table Appendix
-
- Border Report Section 1 – Executive Summary
- Border Report Section 2 – HIV, STDs, and TB in the Texas-Mexico Border Region
- Border Report Section 3 – Population and Demographics of the Texas-Mexico Border Region
- Border Report Section 4 – HIV Diagnoses and People Living with HIV
- Border Report Section 5 – Sexually Transmitted Diseases
- Border Report Section 6 – Tuberculosis
- Border Report – Table Appendix
- HIV and Viral Hepatitis Prevention and Treatment Resources in Texas
-
-
Contractor Resources – HIV Medical and Psychosocial Support Services Open submenu links Close submenu links
-
- Outpatient/Ambulatory Health Services
- Home and Community-Based Health Services
- Referral for Health Care and Support Services
- Non-Medical Case Management
- Home Health Care
- Rehabilitation Services
- Early Intervention Services
- Oral Health Services
- Hospice Services
- Respite Care
- Food Bank – Home Delivered Meals
- Other Professional Services
- Housing Services
- Health Education/Risk Reduction
- Outreach Services
- Linguistic Services
- Health Education-Risk Reduction – Minority AIDS Initiative
- Outreach Services – Minority AIDS Initiative
- Medical Nutrition Therapy
- Health Insurance Premium and Cost Sharing Assistance
- Psychosocial Support Services
- Medical Transportation Services
- Emergency Financial Assistance
- Child Care
- Medical Case Management (including Treatment Adherence Services)
- Mental Health Services
- Substance Abuse Outpatient Care
- Substance Abuse Services (Residential)
- Universal Standards
- Telemedicine Guide Resources
- Telemedicine, Teledentistry, and Telehealth for HIV Core and Support Services
- Primary and Secondary Service Categories
- Public Comment on the Updated HIV Standards of Care
- Housing Opportunities for Persons With AIDS
- HIV Services Program Reports
- Technical Assistance
-
-
-
- THISIS Help Desk
- THISIS Training Manuals
- THISIS Resources and Forms
- THISIS Training Videos
- THISIS Tip Sheets
- THISIS Workflows
-
- THISIS FAQ – Labs
- THISIS FAQ – System Access
- THISIS FAQ – Clinical
- THISIS FAQ – Event
- THISIS FAQ – Follow-Up
- THISIS FAQ – Workflows
- THISIS FAQ – HIV Surveillance
- THISIS FAQ – Notes
- THISIS FAQ – Partner-Clusters
- THISIS FAQ – Public Health Follow-Up
- THISIS FAQ – Reporting-Morbidity
- THISIS FAQ – Reports
- THISIS FAQ – Risk Factors
- THISIS FAQ – Syphilis
- THISIS FAQ – Case Assignment Field Record
- THISIS FAQ – Co-Infection Management
- THISIS FAQ – Congenital Syphilis
- THISIS FAQ – Facilities
- THISIS FAQ - General
- THISIS FAQ – Assigning and Tracking Cases-Field Records
- THISIS FAQ – Helpful Tips
- THISIS Glossary
- DSHS TB/HIV/STD Security and Database Account Management
- Medical Monitoring Project (MMP)
- Texas HIV Surveillance Procedure Manual
- HIV/AIDS Data Changes 2010
-
- Contractor Resources – Routine HIV Testing
-
- HIV/STD Planning
-
-
-
- 700.006 Multi-Month and Special Circumstance Medication Supply and Coverage
- 700.007 Texas Insurance Assistance Program
- PMCY01 Prescription Medication Shortages
- 591.000 The Use of Ryan White Part B Funds for Incarcerated People Living with HIV (PLWH), Recently Released, or Otherwise Judicially Involved in Texas
- 700.003 HIV Medication Participating Site Eligibility Criteria
- 700.004 HIV Medications Ordering Process for Pharmacies
- LIDS 2021.001 Program Income
- 2012.01 Overall Responsible Party for HIV/STD Surveillance Data
- 2011.04 Breach of Confidentiality Response
- 2011.01 Confidential Information Security
- 090.001 Roles and Responsibilities of the Section Regarding Contractors
- 090.020 Model Policies for Handling, Caring and Treating Persons Infected with a Sexually Transmitted Disease (Including HIV/AIDS) While in the Custody, Supervision or Care of Correctional, Law Enforcement, or Emergency Services Entities
- 090.002 HIV Client Services Funding Allocation Formula
- 090.010 Contract Monitoring
- 120.100 HIV Testing of Pregnant Women
- 302.001 Release of Tuberculosis (TB), Human Immunodeficiency Virus (HIV), Sexually Transmitted Disease (STD) and Viral Hepatitis Data
- 530.002 Section Expectations and Provider Rights Regarding the Delivery of Client Service
- 530.003 How to Deal With Clients Who Threaten to Harm Themselves or Others
- 590.001 DSHS Funds as Payment of Last Resort
- 110.002 HIV and STD Prevention Activities in State Prisons and Jails, State Juvenile Justice Facilities, Municipal and County Jails, Federal Prisons, and Private Prisons
- 130.001 Condom Distribution Non-Contracting Prevention Sites
- 220.001 Eligibility to Receive HIV Services
- 231.001 TakeChargeTexas (TCT) Security
- 231.000 TakeChargeTexas (TCT) Users
- 231.002 Administrative Agency Data Managers’ Core Competencies
- 231.003 TCT Data Improvement Plan
- 241.001 Administrative Agency Roles and Responsibilities
- 241.003 Subcontracting HIV Health and Support Services
- 241.004 Administrative Agency Requirements for Community Input
- 241.005 Conflict of Interest in Administrative Agencies
- 241.006 Reallocation of HIV Client Services Funds
- 260.002 Health Insurance Assistance
- 270.001 Calculation of Estimated Expenditures on Covered Clinical Services
- 280.001 Sub-Contracting HIV Core and Support Services by an Administrative Agency
- 420.002 Provider Selection Criteria and Requirements for the Texas Infertility Prevention Project
- 700.001 Texas HIV Medication Program Requests to Change State HIV Medication Formulary
- 700.005 Medicare Part D
- 2020.02 DSHS Central Pharmacy to Dispense Medications to THMP Participants
- 2023.015 Orders for Control of Transmission of HIV and STDs in Texas
- 2023.004 340B Patient Eligibility
- 2023.005 Covered Entity Eligibility and Central Distribution Model Participation
- 2023.006 Prevention of Diversion of 340B Medication
- 2023.008 Covered Entity Ordering and Inventory Tracking
- 2023.009 340B Material Breach Policy
- 2023.010 340B Database Registration, Recertification, and Review
- 2023.011 Penicillin G Benzathine (Bicillin) Treatment
- 2023.013 340B Authorizing Official Back-up
- 2023.007 Prevention of Duplicate Discounts
- 2023.016 340B Roles, Responsibilities, Training and Education
- PIOS User Access
- 700.002 Right to Limit the Number of Clients Assigned to a Pharmacy
- Repealed Policies and Procedures
- Model Workplace Guidelines
-
- 2016.01 HIV/STD Section Confidential Information Security
- 2021.01 Appeals Requests Related to the Texas HIV Medication Program
- 020.050 Public Complaints Related to the Delivery of Section Programs
- 900.002 Completing the Contractor Risk Assessment Tool
- 2020.01 Quality Assurance for the Texas HIV Medication Program’s Eligibility Processes
- HIV/STD Security Policies and Procedures
-
- POPS Chapter 1 – Focused HIV Testing, Counseling, and Linkage to Care for HIV Prevention
- POPS Chapter 2 – Quality Assurance for Focused HIV Testing, Counseling, and Linkage to Care for HIV Prevention
- POPS Chapter 7 – HCV Testing
- POPS Chapter 8 – HIV/STD Surveillance
- POPS Chapter 9 – Disease Intervention Specialist Performance Standards
- POPS Chapter 3 – HIV/STD Partner Services and Seropositive Notification
- POPS Chapter 4 – HIV Testing in STD Clinics
- POPS Chapter 13 – Administrative Agency Core Competencies
- POPS Chapter 10 – First-Line Supervisors Performance Standards
- POPS Chapter 11 – Regional and Local Health Department HIV/STD Program Manager Performance Standards
- POPS Chapter 12 – STD Clinical Standards
- POPS Chapter 16 – Routine HIV Screening in Healthcare Settings
- POPS Chapter 19 - Individual and Group HIV Prevention Interventions
- POPS Chapter 15 – Client Referral Standards
- POPS Chapter 17 - Health Insurance Program Standards
- POPS Chapter 18 – Pick-Up And Delivery Of Prescription And Over-The-Counter Medications Standards
- POPS Chapter 14 – Client File Organization, Content, and Security Standards
- POPS Chapter 22 – Pre-Exposure Prophylaxis (PrEP) and Non-occupational Post-Exposure Prophylaxis (nPEP)
- POPS Chapter 20 – Direct Client Services Volunteer Programs Standards
- POPS Chapter 24 – Structural Interventions for HIV Prevention
- POPS Chapter 23 – Congenital Syphilis
- POPS Chapter 25 – Tangible Reinforcements for HIV Prevention
- POPS Appendix F – CDC Surveillance Case Definitions
- Laws, Rules, and Authorization
-
-
- Records Retention